研究方向：抗肿瘤金属化合物的设计合成

在读期间发表论文：

1. Zhang ZL^#, Zhang JZ#, Yang TF^#, Li SH, Xu G, Liang H*, Yang F*. Developing an anticancer platinum(II) compound based on the uniqueness of human serum albumin. Journal of Medicinal Chemistry, 2023, 66: 5669–5684.

2. Yang TF^#, Zhang ZL^#, Zhang JZ#, Li YP, Li WJ, Liang H*, Yang F*. Developing a gallium(III) agent based on properties of the tumor micro-environment and lactoferrin: Achieving two-agent co-delivery and multi-targeted combination therapy of cancer. Journal of Medicinal Chemistry, 2023, 66: 793−803.

3. Zhang ZL#, Yang TF#, Zhang JZ#, Li WJ, Li SH, Sun HB, Liang H*, Yang F*. Developing a novel indium(III) agent based on human serum albumin nanoparticles: integrating bioimaging and therapy. Journal of Medicinal Chemistry, 2022, 65: 5392−5406. 

4. Zhang JZ, Jiang M, Li SH, Zhang ZL, Sun HB, Yang F*,Liang H*. Developing a novel anticancer gold(III) agent to integrate chemotherapyand immunotherapy. Journal of Medicinal Chemistry, 2021, 64: 6777−6791.

5. Zhang JZ, Zhang ZL, Jiang M, Li SH, Yuan HL, Sun HB, Yang F*, Liang H*. Developing a novel gold(III) agent to treat glioma based onthe unique properties of apoferritin nanoparticles: inducing lethal autophagyand apoptosis. Journal of Medicinal Chemistry, 2020, 63: 13695−13708.

学习经历：

2018/09-2021/12，广西师范大学化学与药学学院(博士)

2015/09-2018/12，广西师范大学化学与药学学院(硕士)

毕业去向：

现就职于桂林医学院，专任教师

邮箱：935780378@qq.com